- Home
- VCIG vs CRIS Comparison
VCIG vs CRIS Comparison
Compare VCIG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCIG | CRIS |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 12.9M |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | VCIG | CRIS |
|---|---|---|
| Price | $9.20 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | ★ 1.0M | 195.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | $1.81 | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.20 | $0.77 |
| 52 Week High | $15.45 | $3.18 |
Technical Indicators
Market Signals| Indicator | VCIG | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 96.34 | 56.34 |
| Support Level | $0.75 | $1.06 |
| Resistance Level | $15.45 | $1.21 |
| Average True Range (ATR) | 0.25 | 0.09 |
| MACD | 0.57 | 0.01 |
| Stochastic Oscillator | 82.08 | 57.68 |
Price Performance
Historical ComparisonAbout VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.